Location History:
- Kyoto, JA (1977)
- Minami Kyoto, JA (1977)
- Kyoto, JP (1980)
- Omi-Yahata, JP (1982)
- Ohmihachiman, JP (1985)
Company Filing History:
4 out of 230 
2 out of 832,891 Years Active: 1977-1985
Title: Kohei Kura: Innovator in Antihyperglycemic Research
Introduction
Kohei Kura, an accomplished inventor based in Omi-Yahata, Japan, has made significant contributions to the field of pharmaceutical science. With a portfolio of 6 patents, Kura's work primarily focuses on developing innovative antihyperglycemic agents that hold promise in the management of blood sugar levels.
Latest Patents
Kura's recent patents exemplify his commitment to advancing diabetes treatment options. His notable inventions include antihyperglycemic moranoline derivatives, specifically N-aralkylmoranoline and N-aralkenylmoranoline. These derivatives, along with their pharmaceutical acceptable non-toxic acid addition salts, are part of compositions designed to inhibit increases in blood sugar levels. Additionally, Kura has developed bis-piperidine compounds, which are characterized by structures like 1,4-bis[3-(2-hydroxymethyl-3,4,5-trihydroxypiperidin-1-yl)prop-2-enyl] benzene. These compounds are recognized as effective antihyperglycemic agents and contribute to essential advancements in diabetes care.
Career Highlights
Throughout his career, Kohei Kura has played an important role in several reputable organizations. Notably, he has worked with Nippon Shinyaku Company, Ltd., where his innovative spirit and expertise have contributed to various pharmaceutical developments.
Collaborations
Kura has collaborated with esteemed colleagues such as Hiroshi Enomoto and Yoshiaki Yoshikuni. Their combined efforts have fostered a rich environment for innovation and have significantly advanced the research surrounding antihyperglycemic therapies.
Conclusion
Kohei Kura's contributions to pharmaceutical innovation, particularly in the field of antihyperglycemic agents, make him a notable figure in contemporary medical research. His patents not only reflect his dedication to improving patient outcomes but also highlight the importance of collaboration in driving advancements in healthcare technology. As the realm of diabetes treatment continues to evolve, Kura's work stands as a beacon of hope for effective management solutions.